2021
Commentary: Psychiatric Presentations of Nonpsychiatric Illness or Treatment
Garakani A. Commentary: Psychiatric Presentations of Nonpsychiatric Illness or Treatment. Journal Of Psychiatric Practice 2021, 27: 404-405. PMID: 34529609, DOI: 10.1097/pra.0000000000000577.Commentaries, Editorials and LettersConceptsManic symptomsPsychiatric historyPerinatal brain injuryOff-label useExamples of patientsPsychogenic nauseaRefractory nauseaGastroesophageal refluxAtypical presentationMood stabilizersSubdural hematomaCertain patientsMedical historyPsychiatric presentationsBrain injuryVisual hallucinationsMedical disordersPsychiatric symptomsPatientsNonpsychiatric illnessCognitive deficitsSuicidal thinkingSymptomsTraditional treatmentBrain imaging
2020
Gaming and Gaming Disorder: A Mediation Model Gender, Salience, Age of Gaming Onset, and Time Spent Gaming
Buono FD, Paul E, Sprong ME, Smith EC, Garakani A, Griffiths MD. Gaming and Gaming Disorder: A Mediation Model Gender, Salience, Age of Gaming Onset, and Time Spent Gaming. Cyberpsychology Behavior And Social Networking 2020, 23: 647-651. PMID: 32654509, DOI: 10.1089/cyber.2019.0445.Peer-Reviewed Original ResearchThe effects of augmenting clozapine with oxytocin in schizophrenia: An initial case series.
Marotta RF, Buono FD, Garakani A, Collins E, Cerrito B, David Rowe DR. The effects of augmenting clozapine with oxytocin in schizophrenia: An initial case series. Annals Of Clinical Psychiatry 2020, 32: 90-96. PMID: 32343282.Peer-Reviewed Case Reports and Technical NotesConceptsTreatment-resistant schizophreniaNegative symptomsAtypical antipsychoticsRetrospective chart reviewInitial case seriesAugmentation of clozapineChronic psychotic illnessNegative Syndrome ScaleYoung adult inpatientsSymptoms of schizophreniaParent/guardian reportsChart reviewCase seriesAdult inpatientsProspective studyAntipsychotic medicationClinical reviewTherapeutic responsePsychotic illnessTreatment approachesSyndrome ScalePositive symptomsTreating psychiatristSymptomsSustained treatment
2019
Pharmacogenomic Testing in Psychiatry: Ready for Primetime?
Rakesh G, Sumner CR, Alexander JL, Gross LS, Pine J, Slaby A, Garakani A, Baron D. Pharmacogenomic Testing in Psychiatry: Ready for Primetime? The Journal Of Nervous And Mental Disease 2019, 208: 127-130. PMID: 31895226, DOI: 10.1097/nmd.0000000000001107.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPatient Requests for Discharge from Voluntary Psychiatric Hospitalization: a Chart Review
Garakani A, Appel JM, Aloysi AS, Martinez JM, Larkin K, Buono FD. Patient Requests for Discharge from Voluntary Psychiatric Hospitalization: a Chart Review. Psychiatric Quarterly 2019, 90: 849-859. PMID: 31468251, DOI: 10.1007/s11126-019-09671-y.Peer-Reviewed Original ResearchConceptsPsychiatric hospitalizationAdmission dayUrine toxicologyVoluntary Psychiatric HospitalizationSuicidal ideationNew York City hospitalsPositive urine toxicologyPrevious psychiatric hospitalizationInpatient psychiatric admissionStepwise linear regression analysisCalendar year 2007Chart reviewEarly dischargePsychiatric admissionsPatient outcomesInpatient careTobacco useCity HospitalPatient's requestInpatient servicesLinear regression analysisCigarette usePsychiatric inpatientsVoluntary admissionHospitalization
2013
Psychosis and Low Cyanocobalamin in a Patient Abusing Nitrous Oxide and Cannabis
Garakani A, Welch AK, Jaffe RJ, Protin CA, McDowell DM. Psychosis and Low Cyanocobalamin in a Patient Abusing Nitrous Oxide and Cannabis. Journal Of The Academy Of Consultation-Liaison Psychiatry 2013, 55: 715-719. PMID: 24367897, DOI: 10.1016/j.psym.2013.11.001.Peer-Reviewed Case Reports and Technical Notes
2012
Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse.
Goldberg JF, Garakani A, Ackerman SH. Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse. The Journal Of Clinical Psychiatry 2012, 73: 1525-30. PMID: 23290325, DOI: 10.4088/jcp.12m07926.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAlcoholismBipolar DisorderCross-Sectional StudiesDiagnosis, Dual (Psychiatry)Diagnostic Self EvaluationFemaleHospitalizationHumansInterview, PsychologicalMaleMass ScreeningMiddle AgedObserver VariationPsychometricsReproducibility of ResultsSubstance-Related DisordersYoung AdultConceptsMood Disorder QuestionnaireBipolar disorderSubstance misusePredictive valueHigh negative predictive valuePatient-clinician concordanceLow positive predictive valueDSM-IV-TR criteriaMood disorder patientsHigh prevalence ratesCross-sectional assessmentCurrent substance misuseSubstance use disordersNegative predictive valuePositive predictive valueSubstance use symptomsPsychiatrist's reviewClinician interviewsPositive statusMood disordersPrevalence ratesMood symptomsLifetime substanceUse disordersBipolar diagnosisCerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment
Garakani A, Martinez JM, Yehuda R, Gorman JM. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment. Journal Of Affective Disorders 2012, 146: 262-265. PMID: 22840611, DOI: 10.1016/j.jad.2012.06.037.Peer-Reviewed Original Research
2008
Effect of medication and psychotherapy on heart rate variability in panic disorder
Garakani A, Martinez JM, Aaronson CJ, Voustianiouk A, Kaufmann H, Gorman JM. Effect of medication and psychotherapy on heart rate variability in panic disorder. Depression And Anxiety 2008, 26: 251-258. PMID: 18839407, DOI: 10.1002/da.20533.Peer-Reviewed Original ResearchConceptsHeart rate variabilityHeart rateRate variabilityLower heart rate variabilitySignificant clinical improvementWeeks of treatmentWeeks of CBTEffects of medicationPanic disorder patientsEffect of treatmentClinical improvementCardiac riskPD patientsCardiovascular diseaseTreatment respondersClinical measuresElevated riskDisorder patientsTreatment phasePatientsSymptom reductionPanic disorderHyperventilation challengeStatistical ManualSignificant decrease